Invention Grant
US09580412B2 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
有权
用于治疗趋化因子介导的疾病的二取代的3,4-二氨基-3-环丁烯-1,2-二酮化合物
- Patent Title: Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
- Patent Title (中): 用于治疗趋化因子介导的疾病的二取代的3,4-二氨基-3-环丁烯-1,2-二酮化合物
-
Application No.: US15175363Application Date: 2016-06-07
-
Publication No.: US09580412B2Publication Date: 2017-02-28
- Inventor: Branislav Musicki , Jerôme Aubert , Jean-Guy Boiteau , Laurence Clary , Patricia Rossio , Marlène Schuppli-Nollet
- Applicant: GALDERMA RESEARCH & DEVELOPMENT
- Applicant Address: FR Biot
- Assignee: GALDERMA RESEARCH & DEVELOPMENT
- Current Assignee: GALDERMA RESEARCH & DEVELOPMENT
- Current Assignee Address: FR Biot
- Agency: Dentons US LLP
- Priority: FR1159833 20111028
- Main IPC: C07D307/14
- IPC: C07D307/14 ; C07D307/54 ; C07D409/06 ; C07D409/14 ; C07D407/06 ; C07D307/16
Abstract:
Methods for preparing disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds that correspond to general formula (I) are described. Also described are pharmaceutical compositions that include the compounds, and methods of using the compounds and compositions for the treatment of chemokine-mediated diseases.
Public/Granted literature
Information query
